Skip to main content
TipRanks
Go Ultimate75% OFF

Jasper Therapeutics (JSPR) Drug Pipeline

1,073 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
BriquilimabUrticaria ChronicPhase IIEnrolling By InvitationA Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria TrialsNov 20, 2024―
BriquilimabAllergic AsthmaPhase ITerminatedA Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic AsthmaSep 06, 2024―
BriquilimabChronic Inducible Urticariaphase1AndPhase2TerminatedA Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- AntihistaminesApr 03, 2024―
BriquilimabChronic Spontaneous Urticariaphase1AndPhase2RecruitingDose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)Nov 21, 2023―
Jsp191Lower-Risk Myelodysplastic SyndromePhase ITerminatedJSP191 (briquilimab) in Subjects with LR-MDSJun 05, 2023―
Humanized Anti-Cd117 Monoclonal Antibody (Jsp191)Scidphase1AndPhase2TerminatedJSP191 Antibody Targeting Conditioning in SCID PatientsNov 02, 2016―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Jasper Therapeutics, Inc. (JSPR) have in its pipeline
Jasper Therapeutics JSPR is currently developing the following drugs: Briquilimab, Jsp191, Humanized Anti-Cd117 Monoclonal Antibody (Jsp191). These drug candidates are in various stages of clinical development as the company works toward FDA approval.